NF 340: Unraveling P2Y11 Receptor Signaling in Immunology and Cancer Research

Principle Overview: NF 340 as a Selective P2Y11 Antagonist

NF 340 (sodium (Z)-N-(3,7-disulfonaphthalen-1-yl)-4-methyl-3-(((Z)-((2-methyl-5-((Z)-oxido((3-sulfo-7-sulfonatonaphthalen-1-yl)imino)methyl)phenyl)imino)oxidomethyl)amino)benzimidate), offered by APExBIO, is a potent and highly selective antagonist of the P2Y11 receptor, a member of the purinergic GPCR family. By competitively inhibiting P2Y11, NF 340 disrupts downstream signaling cascades that modulate inflammation, immune cell migration, and cancer cell invasiveness. This specificity positions NF 340 as a premier tool for researchers probing the nuanced roles of P2Y receptor signaling in disease models, as underscored by both primary literature and comparative analyses (NF 340 product information).

Step-by-Step Experimental Workflow: Optimizing NF 340 for Applied Research

To maximize the scientific value of NF 340 in bench research, careful attention to reagent handling and experimental design is essential. Below, we outline a robust workflow tailored for studies on GPCR signaling, immunology, and inflammation pathway modulation:

• Reagent Preparation: NF 340 is supplied as a beige solid. Dissolve in sterile water or DMSO to a working concentration immediately before use, as the compound demonstrates limited solubility in water (<19.74 mg/ml) and is not amenable to long-term solution storage (product information).
• Cell Treatment: For studies modeling purinergic signaling in cancer or immune cells, pre-treat cells with NF 340 at an empirically determined concentration (commonly in the 1–50 μM range) 30–60 minutes before stimulation with agonists or other pathway modulators. This pre-incubation ensures effective receptor engagement and pathway blockade.
• Assay Read-outs: Downstream effects are typically measured via phosphorylation assays (e.g., myosin light chain phosphorylation in cancer cells), migration/invasion chambers, or cytokine release assays, depending on the research question. Parallel controls without NF 340 and with known P2Y11 agonists/antagonists are crucial for data integrity (reference study).

Protocol Parameters

• NF 340 working concentration: Prepare fresh at 10 μM–20 μM in complete medium; use within 2 hours of dissolution for maximal activity.
• Pre-incubation time: Treat cells with NF 340 for 30–60 minutes prior to stimulation with pathway agonists or QPRT overexpression vectors.
• Storage conditions: Store the dry powder at -20°C; avoid repeated freeze-thaw cycles and do not store solutions longer than 24 hours at 4°C.

Key Innovation from the Reference Study

The pivotal study by Liu et al. ( Frontiers in Endocrinology, 2021) established a novel mechanistic bridge between QPRT-driven NAD+ metabolism and cancer cell invasiveness, revealing that P2Y11 signaling is a critical downstream node. Notably, the use of NF 340 reversed QPRT-induced phosphorylation of myosin light chain and suppressed breast cancer cell migration and invasion. This result provides actionable guidance: incorporating NF 340 in migration/invasion assays enables researchers to directly implicate P2Y11 in cytoskeletal remodeling and metastatic potential. The study’s protocol—pre-treating cells with NF 340 prior to functional assays—serves as a validated blueprint for future experiments dissecting purinergic signaling in both oncology and immunology models.

Advanced Applications and Comparative Advantages

NF 340 stands out among cell signaling inhibitors for its selectivity and reproducibility in complex GPCR signaling contexts. Its utility extends beyond basic research:

• In immunology research, NF 340 enables precise modulation of P2Y11-driven cytokine release and immune cell migration, facilitating studies on inflammation and immune response modulation (related article).
• In cancer biology, the compound’s ability to abrogate QPRT-driven invasiveness positions it as a gold-standard tool for mechanistic studies in metastasis and pathway dissection (extension article).
• Workflow compatibility is robust: NF 340 performs reliably in both 2D and 3D cell culture systems, migration/invasion assays, and advanced imaging platforms, supporting high-content and high-throughput applications (protocol guide).

Compared to less selective P2Y receptor inhibitors, NF 340 provides reduced off-target effects and clearer mechanistic attribution, as highlighted in multiple comparative analyses.

Troubleshooting & Optimization Tips

• Solubility management: Given its limited water solubility, always dissolve NF 340 in DMSO for higher stock concentrations, then dilute into aqueous media immediately before use. Avoid vigorous vortexing which can introduce particulates—gentle mixing is preferred.
• Batch-to-batch consistency: When scaling up for high-throughput screening, validate each lot with a control assay (e.g., P2Y11 agonist-induced cAMP response) to ensure consistent antagonist activity.
• Assay specificity: NF 340’s high selectivity allows for precise pathway interrogation; however, include vehicle and unrelated receptor antagonists in parallel to confirm specificity in novel cell lines or systems.
• Minimizing compound degradation: Prepare aliquots under inert atmosphere if possible and limit exposure to ambient light and repeated freeze-thaw cycles, as recommended in the product documentation.

Future Outlook

The integration of NF 340 into experimental workflows is poised to accelerate discoveries in both inflammation pathway modulation and metastasis research. The clear demonstration by Liu et al. that P2Y11 signaling links metabolic reprogramming to cytoskeletal changes in breast cancer underscores the translational promise of purinergic pathway targeting. As more studies adopt selective P2Y11 antagonists like NF 340, the field will gain increasingly nuanced insight into the intersection of GPCR signaling, immune function, and tumor progression. Ongoing advances in high-content phenotyping and single-cell analytics will further leverage NF 340’s reproducibility and specificity, establishing new standards for assay rigor and actionable data.